ENVB

Enveric Biosciences

Stock NASDAQ – Stock Market Prices, News & Analysis

Enveric Biosciences Inc focuses on the development of cannabinoid-based therapies for healthcare applications.

$ 1.99
1.00 %

Enveric Biosciences

$ 1.99
1.00 %
ENVB

Enveric Biosciences Inc focuses on the development of cannabinoid-based therapies for healthcare applications.

Price history of Enveric Biosciences
Price history of Enveric Biosciences

Performance & Momentum

6 Months 78.96 %
1 Year 86.52 %
3 Years 99.95 %
5 Years 100.00 %

Strategic Analysis

Enveric Biosciences • 2026

Enveric Biosciences Inc positions itself in the biotechnology sector by developing innovative cannabinoid-based therapies, targeting medical needs that remain largely unmet. Its model is based on the exploration of cannabinoid molecules for therapeutic applications, leveraging clinical research and scientific advances in this niche field.

Strengths
  • Specialized expertise in cannabinoid biotechnology, an emerging segment with strong medical potential
  • Focus on medical indications not addressed by conventional treatments, providing a differentiated positioning
Weaknesses
  • Very poor stock performance over the past few years, reflecting operational or strategic difficulties
  • Near-zero momentum and a lack of recent catalysts limiting investor appeal
Momentum

Momentum is extremely weak, with a marked downward trend over the medium and long term, reflecting an unfavorable environment both operationally and financially. This dynamic calls for caution, as the company will need to demonstrate clear progress in its clinical programs to reverse market sentiment.

Similar stocks to Enveric Biosciences

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone